RPQ9 (EAEA), transverse colon, section 32, 4d post-ATI
source_name
Transverse colon
tissue
Transverse colon
treatment
EAEA group (transient reservoir model): challenged intravaginally/intrarectally with a 2000 TCID50 dose of SIVmac239; suppressive ART initiated 4 days post-infection and maintained for 193 days (~6 months) before analytical treatment interruption (ATI); necropsied 4 days post-ATI, during the pre-viremic eclipse phase.
batch
RPQ9
tissue preservation_method
fresh frozen, optimal cutting temperature (OCT) compound
slide parameters
V12-U06-122 B1
geo_loc_name
missing
collection_date
missing